Travel Linked to Higher TB Test Conversion Risk

A California study reveals international travel significantly increases the likelihood of tuberculosis test conversion.

Updated on Oct. 21, 2026 in Asthma

Bold flat-color editorial illustration of a medical vial, representing clinical research into tuberculosis screening protocols. — A California study identifies international travel as a significant factor in increased tuberculosis test conversion rates among Asian American patients. AI Illustration. Upload story photo >

Live Poll

Should healthcare providers routinely include international travel history in tuberculosis risk assessments?

Researchers found that international travel is associated with 95% higher odds of tuberculosis test conversion among Asian American patients in California. The study analyzed data from thousands of patients to understand infection risks in routine screenings.

Why it matters

Understanding the link between travel history and test results helps clinicians better assess tuberculosis risks. This insight could lead to more effective screening protocols for patients with a recent history of international travel.

A study of 5,668 patients showed a 3.0% test conversion rate among routine testers, with 119 individuals identified as converters. Participants were 94% Asian, with 3.2% of IGRA tests and 2.9% of TST tests showing conversion.

The players

Asian American patients

This group comprised 94% of the cohort analyzed in the study regarding tuberculosis screening outcomes.

The details

The research conducted in the San Francisco Bay Area matched 119 test converters against 338 non-converters to isolate the impact of travel. While 100 converters were diagnosed with latent tuberculosis, only 57% initiated treatment and 65% finished the required course, with two patients developing active disease.

The retrospective study collected data from 2010 to 2022.
Researchers finalized the linking of converters to the TB registry in 2023.
The findings were officially published on October 9, 2026.

Health Landscape

These findings suggest that travel history may need to be integrated into the current Centers for Disease Control and Prevention's TB risk-based testing guidelines. Moving beyond static risk factors to incorporate dynamic travel data could refine how healthcare providers target diagnostic resources.

Patients who have recently traveled internationally should disclose this history to their healthcare providers during routine check-ups. Being proactive about sharing travel details can help physicians determine if additional tuberculosis screening is medically appropriate.

The takeaway

Maintaining transparency about your international travel history is a critical step in ensuring accurate health assessments for infections like tuberculosis. Patients should prioritize completing prescribed latent infection treatments to prevent the potential progression into active disease.